Apollomics Shares Are Trading Lower After the Company Announced Its Phase 3 Bridging Trial of Uproleselan in China Did Not Demonstrate a Favorable Benefit.
Apollomics Shares Are Trading Lower After the Company Announced Its Phase 3 Bridging Trial of Uproleselan in China Did Not Demonstrate a Favorable Benefit.
Apollomics的股票在公司宣布其在中国的Uproleselan III期桥接试验未能显示出有利的益处后，交易下跌。
Apollomics Shares Are Trading Lower After the Company Announced Its Phase 3 Bridging Trial of Uproleselan in China Did Not Demonstrate a Favorable Benefit.
Apollomics的股票在公司宣布其在中国的Uproleselan III期桥接试验未能显示出有利的益处后，交易下跌。
资讯热榜
更新时间